LIS
FLNA

Legacy Investment Solutions’s Filana Therapeutics FLNA Stock Holding History

Legacy Investment Solutions’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$467 Buy
+258
New +$459 ﹤0.01% 657
2024
Q4 		$586 Hold
258
– – ﹤0.01% 643
2024
Q3 		$6.5K Buy
+258
New +$5.94K ﹤0.01% 364

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Legacy Investment Solutions's FLNA Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Filana Therapeutics (FLNA) in Q2 2025: 258 shares worth $467. The stake represents ﹤0.01% of the portfolio and ranks #657 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in FLNA as recently as Q4 2024.

Legacy Investment Solutions first reported a position in FLNA in Q3 2024 and has held it in 3 quarters since. The position peaked at $6.5K in Q3 2024. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Legacy Investment Solutions held 258 shares of Filana Therapeutics worth $467 as of Q2 2025.
  • Filana Therapeutics was a new Legacy Investment Solutions position in Q2 2025.
  • Filana Therapeutics made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #657 holding.
  • Legacy Investment Solutions first reported a position in Filana Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's Filana Therapeutics position peaked at $6.5K in Q3 2024.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.